Literature DB >> 9209862

Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertension.

H Jick1, C Vasilakis, L E Derby.   

Abstract

We conducted a case-control study to evaluate the risk of fatal myocardial infarction in otherwise healthy treated hypertensive subjects according to the type of the antihypertensive drug used. The study encompassed 207 cases and 409 controls matched to cases on age, sex, and general practice. Compared with beta-blocker users, the matched relative risk estimates for fatal myocardial infarction, adjusted for recent blood pressure, body mass index, smoking, duration of hypertension, and prior use of other antihypertensive drugs, were 0.7 [95% confidence interval (CI) = 0.4-1.2] for angiotensin-converting enzyme inhibitor users, 0.9 (95% CI = 0.5-1.5) for calcium channel blocker users, and 0.7 (95% CI = 0.4-1.2) for diuretic users.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209862     DOI: 10.1097/00001648-199707000-00017

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  7 in total

1.  Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction.

Authors:  C R Meier; R G Schlienger; H Jick
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

2.  Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.

Authors:  Raymond G Schlienger; Lorenz M Fischer; Hershel Jick; Christoph R Meier
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

3.  Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  BMJ       Date:  2005-06-11

4.  Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.

Authors:  Julia Hippisley-Cox; Carol Coupland; Richard Logan
Journal:  BMJ       Date:  2005-12-03

5.  No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease.

Authors:  Mark T Osterman; Yu-Xiao Yang; Colleen Brensinger; Kimberly A Forde; Gary R Lichtenstein; James D Lewis
Journal:  Clin Gastroenterol Hepatol       Date:  2011-07-13       Impact factor: 11.382

6.  Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction.

Authors:  Raymond G Schlienger; Hershel Jick; Christoph R Meier
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

7.  General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.

Authors:  L J Tata; J West; C Smith; P Farrington; T Card; L Smeeth; R Hubbard
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.